Brad Robertson

Brad Robertson is a self-driven scientist with nine years of professional experience in the pharmaceutical industry, currently serving as a Sr. Scientist in Oligonucleotide Process Development at Biogen. Robertson has a proven track record in process development, optimization, and scale-up, contributing to significant projects such as first-in-human clinical trials and regulatory submissions. Previous roles include Research Scientist II at Chimerix, Inc., and Head of Chemistry at Maku Technologies, where they led chemistry activities and optimized processes for clinical research. Robertson earned a Ph.D. in Organic Chemistry from Duke University, where they focused on natural products total synthesis and methodology. They completed a Bachelor of Science in Chemistry and Biology at Winthrop University, graduating summa cum laude.